From: 39th International Symposium on Intensive Care and Emergency Medicine
Secondary Outcomes | Aspirin (n=23) | Placebo (n=25) | p-value |
---|---|---|---|
Length of ICU stay, days | 4.1 [2.2-8.7] | 4.9 [3.4-8] | 0.37 |
ICU mortality – no (%) | 0 | 2 (8) | 0.49 |
Hospital mortality – no (%) | 1 (4.3) | 2 (8.0) | >0.99 |
28-day mortality – no. (%) | 1 (4.3) | 2 (8.0) | >0.99 |
Patient with transfusion in ICU – no. (%) | 3 (13.0) | 3 (12.0) | >0.99 |
Episodes of clinically identified bleeding in ICU | 0 | 0 | - |
Lowest platelet count in ICU, x1000/mm3 | 186 [112-228] | 164 [120-238] | 0.88 |